House looks to weaken Medicare negotiation
A House panel is hearing two bills that weaken different requirements in Medicare's drug price negotiation program
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Operation Tweak the IRA commences
Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy & Commerce subcommittee today.
What's Your Reaction?
